Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the cancer care outcomes research and Surveillance Consortium

Mary E. Charlton, Chi Lin, Dingfeng Jiang, Karyn B. Stitzenberg, Thorvardur R. Halfdanarson, Jane F. Pendergast, Elizabeth A. Chrischilles, Robert B. Wallace

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop CRT. We examined patient beliefs and clinical and provider characteristics associated with receipt of recommended therapy. Methods: We identified stages II/III rectal cancer patients who had primary site resection and CRT among subjects in the Cancer Care Outcomes Research and Surveillance Consortium, a population-based and health system-based prospective cohort of newly diagnosed colorectal cancer patients from 2003 to 2005. Patient surveys and abstracted medical records were used to construct variables and determine sequence of CRT and surgery. Logistic regression was used to model the association between predictors and receipt of preop CRT. Results: Of the 201 patients, 66% received preop and 34% received postop CRT. Those visiting a medical oncologist and/or radiation oncologist before a surgeon had a 96% (95% confidence interval, 92%-100%) predicted probability of receiving preop CRT, compared with 48% (95% confidence interval, 41%-55%) for those visiting a surgeon first. Among those visiting a surgeon first, documentation of recommended staging procedures was associated with receiving preop CRT. Conclusions: Sequence of provider visits and documentation of recommended staging procedures were important predictors of receiving preop CRT. Initial multidisciplinary evaluation led to better adherence to CRT guidelines. Further evaluation of provider characteristics, referral patterns, and related health system processes should be undertaken to inform targeted interventions to reduce variation from recommended care.

Original languageEnglish (US)
Pages (from-to)572-579
Number of pages8
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume36
Issue number6
DOIs
StatePublished - Dec 1 2013

Fingerprint

Rectal Neoplasms
Outcome Assessment (Health Care)
Neoplasms
Therapeutics
Documentation
Confidence Intervals
Health
Medical Records
Colorectal Neoplasms
Referral and Consultation
Logistic Models
Guidelines

Keywords

  • Chemotherapy
  • Practice variation
  • Radiation therapy
  • Rectal cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the cancer care outcomes research and Surveillance Consortium. / Charlton, Mary E.; Lin, Chi; Jiang, Dingfeng; Stitzenberg, Karyn B.; Halfdanarson, Thorvardur R.; Pendergast, Jane F.; Chrischilles, Elizabeth A.; Wallace, Robert B.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 36, No. 6, 01.12.2013, p. 572-579.

Research output: Contribution to journalArticle

Charlton, Mary E. ; Lin, Chi ; Jiang, Dingfeng ; Stitzenberg, Karyn B. ; Halfdanarson, Thorvardur R. ; Pendergast, Jane F. ; Chrischilles, Elizabeth A. ; Wallace, Robert B. / Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the cancer care outcomes research and Surveillance Consortium. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2013 ; Vol. 36, No. 6. pp. 572-579.
@article{2539e21eb83047c589358f189a927db3,
title = "Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the cancer care outcomes research and Surveillance Consortium",
abstract = "Purpose: Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop CRT. We examined patient beliefs and clinical and provider characteristics associated with receipt of recommended therapy. Methods: We identified stages II/III rectal cancer patients who had primary site resection and CRT among subjects in the Cancer Care Outcomes Research and Surveillance Consortium, a population-based and health system-based prospective cohort of newly diagnosed colorectal cancer patients from 2003 to 2005. Patient surveys and abstracted medical records were used to construct variables and determine sequence of CRT and surgery. Logistic regression was used to model the association between predictors and receipt of preop CRT. Results: Of the 201 patients, 66{\%} received preop and 34{\%} received postop CRT. Those visiting a medical oncologist and/or radiation oncologist before a surgeon had a 96{\%} (95{\%} confidence interval, 92{\%}-100{\%}) predicted probability of receiving preop CRT, compared with 48{\%} (95{\%} confidence interval, 41{\%}-55{\%}) for those visiting a surgeon first. Among those visiting a surgeon first, documentation of recommended staging procedures was associated with receiving preop CRT. Conclusions: Sequence of provider visits and documentation of recommended staging procedures were important predictors of receiving preop CRT. Initial multidisciplinary evaluation led to better adherence to CRT guidelines. Further evaluation of provider characteristics, referral patterns, and related health system processes should be undertaken to inform targeted interventions to reduce variation from recommended care.",
keywords = "Chemotherapy, Practice variation, Radiation therapy, Rectal cancer",
author = "Charlton, {Mary E.} and Chi Lin and Dingfeng Jiang and Stitzenberg, {Karyn B.} and Halfdanarson, {Thorvardur R.} and Pendergast, {Jane F.} and Chrischilles, {Elizabeth A.} and Wallace, {Robert B.}",
year = "2013",
month = "12",
day = "1",
doi = "10.1097/COC.0b013e318261082b",
language = "English (US)",
volume = "36",
pages = "572--579",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the cancer care outcomes research and Surveillance Consortium

AU - Charlton, Mary E.

AU - Lin, Chi

AU - Jiang, Dingfeng

AU - Stitzenberg, Karyn B.

AU - Halfdanarson, Thorvardur R.

AU - Pendergast, Jane F.

AU - Chrischilles, Elizabeth A.

AU - Wallace, Robert B.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Purpose: Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop CRT. We examined patient beliefs and clinical and provider characteristics associated with receipt of recommended therapy. Methods: We identified stages II/III rectal cancer patients who had primary site resection and CRT among subjects in the Cancer Care Outcomes Research and Surveillance Consortium, a population-based and health system-based prospective cohort of newly diagnosed colorectal cancer patients from 2003 to 2005. Patient surveys and abstracted medical records were used to construct variables and determine sequence of CRT and surgery. Logistic regression was used to model the association between predictors and receipt of preop CRT. Results: Of the 201 patients, 66% received preop and 34% received postop CRT. Those visiting a medical oncologist and/or radiation oncologist before a surgeon had a 96% (95% confidence interval, 92%-100%) predicted probability of receiving preop CRT, compared with 48% (95% confidence interval, 41%-55%) for those visiting a surgeon first. Among those visiting a surgeon first, documentation of recommended staging procedures was associated with receiving preop CRT. Conclusions: Sequence of provider visits and documentation of recommended staging procedures were important predictors of receiving preop CRT. Initial multidisciplinary evaluation led to better adherence to CRT guidelines. Further evaluation of provider characteristics, referral patterns, and related health system processes should be undertaken to inform targeted interventions to reduce variation from recommended care.

AB - Purpose: Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop CRT. We examined patient beliefs and clinical and provider characteristics associated with receipt of recommended therapy. Methods: We identified stages II/III rectal cancer patients who had primary site resection and CRT among subjects in the Cancer Care Outcomes Research and Surveillance Consortium, a population-based and health system-based prospective cohort of newly diagnosed colorectal cancer patients from 2003 to 2005. Patient surveys and abstracted medical records were used to construct variables and determine sequence of CRT and surgery. Logistic regression was used to model the association between predictors and receipt of preop CRT. Results: Of the 201 patients, 66% received preop and 34% received postop CRT. Those visiting a medical oncologist and/or radiation oncologist before a surgeon had a 96% (95% confidence interval, 92%-100%) predicted probability of receiving preop CRT, compared with 48% (95% confidence interval, 41%-55%) for those visiting a surgeon first. Among those visiting a surgeon first, documentation of recommended staging procedures was associated with receiving preop CRT. Conclusions: Sequence of provider visits and documentation of recommended staging procedures were important predictors of receiving preop CRT. Initial multidisciplinary evaluation led to better adherence to CRT guidelines. Further evaluation of provider characteristics, referral patterns, and related health system processes should be undertaken to inform targeted interventions to reduce variation from recommended care.

KW - Chemotherapy

KW - Practice variation

KW - Radiation therapy

KW - Rectal cancer

UR - http://www.scopus.com/inward/record.url?scp=84892603127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892603127&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e318261082b

DO - 10.1097/COC.0b013e318261082b

M3 - Article

VL - 36

SP - 572

EP - 579

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 6

ER -